Attralus, Inc. photograph

Attralus, Inc.

Use attributes for filter !
Founded2019
Date of Reg.
Date of Upd.
ID4031113
Send edit request

About Attralus, Inc.


Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients with systemic amyloidosis. Its proprietary peptide-based pan-amyloid targeting agents have the potential to diagnose and treat all forms and stages of systemic amyloidosis.

Next Profile ❯